Ask AI

Year in Review in EGFR-Mutated NSCLC: Impact of Recent Advances Across the Disease Continuum    

Advance your understanding of current guideline-based recommendations for the management of EGFR-mutated NSCLC to individualize treatment plans and improve patient outcomes through a certified on-demand webcast and downloadable slides.

Share

Program Content

Events

Activities

1L Therapy for EGFRm NSCLC
Year in Review in EGFR-Mutated NSCLC: First-line Therapy Selection for EGFRm NSCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 22, 2026

Treatment for Advanced EGFRm NSCLC
Year in Review in EGFR-Mutated NSCLC: Treatment Strategies for 2L+ and Exon 20 Insertions
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 22, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

 

Supporters

Supported by an educational grant from Johnson & Johnson.

 

Johnson & Johnson